Synairgen shares rise after announcing 'excellent progress' in separate studies 1 234 567

Synairgen shares rise after announcing 'excellent progress' in separate studies

www.livecharts.co.uk

Synairgen announced on Wednesday it had narrowed its operating loss for the six months leading to 30 June thanks to "excellent progress" made in the development of its Lysyl Oxidase-Like 2 (LOXL2) enzyme inhibitor, and its AZD9412 (SNG001) programme.

Full news

Share:

More:

US Retailers Look to Profitable Black Friday Weekend 1 234 567

US Retailers Look to Profitable Black Friday Weekend

The U.S. holiday shopping season shifts into high gear this week after the Thanksgiving Day Holiday on Thursday....

www.voanews.com

US Retailers Look to Profitable Black Friday Weekend 1 234 567

US Retailers Look to Profitable Black Friday Weekend

The U.S. holiday shopping season shifts into high gear this week...

www.voanews.com